I now see that Palatin has commenced a P2 trial for ED (n=50, topline results 6/12). Palatin are trialling MT2 for ED and weight loss. both in combination with PDE5i and GLP1 drugs. Weight loss, frying pan handle boners, if only there was a way of getting a tan. The ultimate barbie drug.
Ann: CLINUVEL Newsletter III - June 2024, page-32
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.66 |
Change
-0.080(0.54%) |
Mkt cap ! $735.1M | |||
| Open | High | Low | Value | Volume |
| $14.74 | $14.77 | $14.50 | $361.9K | 24.76K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 70 | $14.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.67 | 69 | 5 |
View Market Depth
| Last trade - 13.51pm 30/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |